Equity Analysis /
United States of America

US : Teva Pharmaceutical Industries Ltd. - TEVA | TEVA Receives Second gX Approval of NuvaRing, Helping Bolster U.S. Generics Growth Case

    Lucas Lee
    Lucas Lee

    Sr. Res. Assoc.

    Follow
    CGS-CIMB
    15 January 2021
    Published byCGS-CIMB

    On the heels of CEO Kåre Schultz reiterating confidence in putting Teva back in growth mode, the company lands a long-awaited product catalyst receiving the second FDA generic approval for Merck’s NuvaRing (etonogestrel/ethinyl estradiol vaginal ring). The approval comes on the heels of management